Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at raps@raps.org if you need assistance.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Our new book is a comprehensive look at a vital part of medicines development and regulatory affairs. Grab your copy today!
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
The US Food and Drug Administration (FDA) found a slew of good laboratory practice (GLP) violations during the conduct of nonclinica...
Welcome to Regulatory Reconnaissance, your daily regulatory news and intelligence briefing.
Providing both benefit and risk information within character-space-limited (CSL) drug promotions on social media platforms like Twit...
MDCG created the guidance to support designating authorities responsible for assessing applications for medical device and in vitro ...
According to a US Food and Drug Administration (FDA) lawyer, the European Union’s privacy regulations are a headache for researchers...
16 Aug 2022
18 Aug 2022 | St Louis Park,USA
24 Aug 2022